Research
Cellular
GLP-1 receptor agonists (GLP-1RAs) may help manage psoriasis (PsO) and psoriatic arthritis (PsA) in patients with obesity.
Clinicians may consider GLP-1RAs as a treatment option for obese patients with PsO and PsA.
StrongSupportsmedium confidence
Recent studies also suggest that GLP-1RAs may help manage PsO and PsA in patients with obesity.
Why this rating
The claim is based on recent studies, indicating a strong level of evidence.
Source
What Clinicians Need to Know About Glucagon-like Peptide 1 Agonists
Dimitri Luz Felipe da Silva et al. · The Journal of Rheumatology · 2025
DOI 10.3899/jrheum.2025-0531
reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →